Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Small (Weinheim an Der Bergstrasse, Germany)|October 7, 2022
3D-Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient-Derived Glioma CellsNastaran Barin, Hayri E Balcioglu, Iris de Heer, et al.Cancers|September 9, 2022
Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer PatientsChumut Phanthunane, Rebecca Wijers, Maria J De Herdt, et al.Frontiers in Oncology|September 18, 2023
GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approachesMarjolein Verhoeven, Eline A M Ruigrok, Geert J L H van Leenders, et al.Cancers|June 2, 2021
V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple MyelomaPim Mutsaers, Hayri E Balcioglu, Rowan Kuiper, et al.Neuro-Oncology|May 31, 2022
Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markersIris S C Verploegh, Andrea Conidi, Rutger W W Brouwer, et al.Journal of Hematology & Oncology|July 19, 2024
Lipid-based nanosystems: the next generation of cancer immune therapyZiyun Cheng, Seth-Frerich Fobian, Elena Gurrieri, et al.Cells|May 16, 2023
Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle PhasePieter A Roelofs, Mieke A M Timmermans, Bojana Stefanovska, et al.Nature Communications|September 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancerDora Hammerl, John W M Martens, Mieke Timmermans, et al.Nature Communications|January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytomaLevi van Hijfte, Marjolein Geurts, Iris de Heer, et al.Cancers|March 29, 2023
Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon RadiotherapyShweta Mahajan, Hayri E Balcioglu, Astrid Oostvogels, et al.Pageof 3